Cancer Institute of New Jersey at the Cooper University Hospital — Camden, New Jersey

Cancer Institute of New Jersey at the Cooper University Hospital is a clinical research site located in Camden, New Jersey, United States 08103.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Cancer Institute of New Jersey at the Cooper University Hospital has participated in 14 clinical trials.

Therapeutic areas: Lung Cancer, Lymphoma, Endometrial Cancer.

Sponsors: Alliance for Clinical Trials in Oncology, Gynecologic Oncology Group, Radiation Therapy Oncology Group.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Cancer Institute of New Jersey at the Cooper University Hospital?

Cancer Institute of New Jersey at the Cooper University Hospital has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Cancer Institute of New Jersey at the Cooper University Hospital conducted?

Cancer Institute of New Jersey at the Cooper University Hospital has 14 clinical trials on record. Their work covers Lung Cancer, Lymphoma, Endometrial Cancer.

Is Cancer Institute of New Jersey at the Cooper University Hospital accredited by Crixeo Health?

Yes — Cancer Institute of New Jersey at the Cooper University Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Cancer Institute of New Jersey at the Cooper University Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.